Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
1 clinical trials · Condition
◉ Watch Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
| Record | Firm | Date |
|---|---|---|
| Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive (NCT03178071) | Pfizer |
Track Non Small Cell Lung Cancer ALK Positive or ROS1 Positive automatically
Every clearance here is in the API, with alerts when new ones post.